|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Enhanced recovery after surgery: A consensus review of clinical care for patients undergoing colonic resection显示文摘 | K.C.H. Fearon O. Ljungqvist M. Von Meyenfeldt A. Revhaug C.H.C. Dejong K. Lassen J. Nygren J. Hausel M. Soop J. Andersen H. Kehlet | 2005 | Clinical Nutrition2005，，3： | 3 |
| 2 | 当前围手术期处理模式:北欧五国结直肠外科医生调查显示文摘 | Kristoffer Lassen Pascal Hannemann Olle Ljungqvist Ken Fearon Cornelis H C Dejong Maarten F von Meyenfeldt Jonatan Hausel Jonas Nygren Jens Andersen Arthur Revhaug 王东 | 2005 | 英国医学杂志中文版2005，8，6： | 3 |
| 3 | Fondaparinux预防老年急性内科患者发生静脉血栓形成的效果与安全性:随机安慰剂对照研究显示文摘目的:观察 Fondaparinux 对具有中高度静脉血栓发生危险的老年急性内科住院患者的抗凝效果与安全性。设计:双盲随机安慰剂对照研究。背景:8个国家的35个中心。参与者:849例≥60岁内科患者,住院原因分别为充血性心力衰竭、慢性肺病合并急性呼吸系统疾患、急性炎症性或感染性疾病,预期至少住院4天以上。干预:2.5 mg Fondaparinux 或安慰剂,每天1次皮下注射,持续6~14天。观察指标:主要指标为静脉血栓形成(治疗后15天内采用双侧静脉造影检查)及有症状的静脉血栓;次要指标为死亡与出血。患者随访时间为1个月。结果:Fondaparinux 治疗组425例患者和安慰剂组414例患者接受了安全性分析(10例未治疗)。644例患者(75.9%)可接受主要指标分析。静脉血栓检出率在 Fondaparinux 治疗组为5.6%(18/321),安慰剂组为10.5%(34/323),相对危险减少46.7%(95% CI 7.7%~69.3%)。安慰剂组5例患者发生有症状的静脉血栓,Fondaparinux治疗组无患者发生有症状的静脉血栓(P=0.029)。两组均有1例(0.2%)患者发生严重出血。随访结束时,安慰剂组、Fondaparinux 治疗组分别死亡25(6.0%)、14(3.3%)例患者。结论:Fondaparinux 可有效预防急性内科老年患者无症状性及有症状的静脉血栓。严重出血几率两组相似。 | Alexander T Cohen Bruce L Davidson Alexander S Gallus Michael R Lassen Martin H Prins Witold Tomkowski Alexander G G Turpie Jan F M Egberts Anthonie W A Lensing 石汉平(译) 王深明(校) | 2006 | 英国医学杂志中文版2006，9，5： | 3 |
| 4 | Dokk1多媒体图书馆显示文摘项目名称:Dokk1多媒体图书馆建设地点:丹麦奥胡斯业主:奥胡斯市政府设计单位:Schmidt Hammer Lassen Architects合作单位:Realdania设计顾问:Arkitekt Kristine Jensens Tegnestue,Alectia Consulting Engineers建筑面积:35 600 m^2建筑层数:5工程公司:Alectia R dgivende Ingeni rer客户合伙人:Realdania客户咨询公司:Ramb ll Danmark其他咨询顾问:Bahn arkitekter(accessibility)设计总负责:Kim Holst Jensen(Schmidt Hammer Lassen Architects) | Schmidt Hammer Lassen Architects | 2016 | 城市建筑2016，0，34： | 2 |
| 5 | Treatment with corticosteroids and the risk of anastomotic leakage following lower gastrointestinal surgery: a literature survey显示文摘 | T. F. Eriksen C. B. Lassen I. G?genur | 2014 | Colorectal Dis2014，，5： | 2 |
| 6 | Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty显示文摘 | Lassen MR Ageno W Borris LC | 2008 | N Engl J Med2008，358，26： | 1 |
| 7 | Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck显示文摘 | Lassen P Eriksen JG Hamilton-Dutoit S | | 0，，12： | 1 |
| 8 | Apixaban or enoxaparin for thromboprophylaxis after knee replacement 显示文摘 | Lassen MR Raskob GE Gallus A | 2009 | New E J Med2009，361，： | 1 |
| 9 | Complicated and uncomplicated peptic ulcers in a Danish county 1993- 2002 : a population-based cohort study显示文摘 | Lassen A Hallas J de Muckadell OBS | 2006 | Amer 3' Gastro- enterol2006，101，5： | 1 |
| 10 | Rivaroxaban versus enoxaparin for thromboprophylaxis after total, knee arthroplasty (RECORD4) : a randomised trial 显示文摘 | Turpie AG Lassen MR Davidson BL | 2009 | Lancet2009，373，： | 1 |
| 11 | Invasive coronary treatment strategies for out-of-hospital cardiac arrest: a consensus statement from the European association for percutaneous cardiovascular in- terventions(EAPCl)/stent for Iife(SFL) groups显示文摘 | Noc M Fajadet J Lassen J F | 2014 | Euro Inter- vention2014，10，1： | 1 |
| 12 | Lack of agreement between biochemical and genetic identification of Aeromonas spp显示文摘 | Ormen O Granum PE Lassen J | 2005 | APMIS2005，113，3： | 1 |
| 13 | Combined treatment with antibacterial che-motherapeutical agents in Staphylococcal infections显示文摘 | Jensen K Lassen HC | 1969 | Q J Med1969，38，149： | 1 |
| 14 | Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4):a randomised trial显示文摘 | Turpie AG Lassen MR Davidson BL | 2009 | Lancet2009，373，9676： | 1 |
| 15 | Phase I-II dose escalation study of fixed-dose rate gemcitabine, oxaliplatin and capecitabine every two weeks in advanced cholangiocarcinomas显示文摘 | Lassen D Jensen L H Soremen M A | 2011 | Acta Oncol2011，50，3： | 1 |
| 16 | The consensus concept for thermostability engineering of proteins 显示文摘 | Lehmann M Pasamontes L Lassen SF Wyss M | 2000 | Biochimica et Biophysica Acta (BBA) -Protein Structure and Molecular Enzy- mology2000，1543，2： | 1 |
| 17 | Experimental Entanglement Distillation of Macroscopic Quantum States 显示文摘 | DONG RUIFANG LASSEN MIKAEL HEERSINK JOEL | 2008 | Nature Physics2008，4，： | 1 |
| 18 | Nitric-oxide synthase inhibition in migraine 显示文摘 | Lassen L H Ashina M Christiansen I | 1997 | Lancet1997，349，9049： | 1 |
| 19 | Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty显示文摘 | Lassen MR Ageno W Borris LC | | 0，，26： | 1 |
| 20 | Apixaban or enoxaparin for thromboprophylaxis after knee replacement 显示文摘 | Lassen MR Raskob GE Gallus A | 2009 | N Engl J Med2009，361，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员